We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+11.67%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$9.22B
AUM Growth
+$331M
(+3.7%)
Cap. Flow
-$371M
Cap. Flow
% of AUM
-4.02%
Top 10 Holdings %
Top 10 Hldgs %
56.36%
Holding
1,043
New
155
Increased
182
Reduced
486
Closed
210
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hess Midstream
HESM
|
+$149M |
| 2 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$105M |
| 3 |
CEQP
Crestwood Equity Partners LP
CEQP
|
+$97.9M |
| 4 |
MPLX
MPLX
|
+$74.6M |
| 5 |
DCP
DCP Midstream, LP
DCP
|
+$63.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Western Midstream Partners
WES
|
+$541M |
| 2 |
PSXP
PHILLIPS 66 PARTNERS LP
PSXP
|
+$338M |
| 3 |
Williams Companies
WMB
|
+$35.8M |
| 4 |
ExxonMobil
XOM
|
+$29.6M |
| 5 |
Verizon
VZ
|
+$25.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 65.72% |
| 2 | Technology | 5.09% |
| 3 | Consumer Discretionary | 3.8% |
| 4 | Healthcare | 3.45% |
| 5 | Industrials | 3.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Regenxbio
RGNX
$630M
| $1.47M | 0.02% |
44,138
-5,353
| -11% | -$149K |
|
|
AAT
277
American Assets Trust
AAT
$1.51B
| $1.43M | 0.02% |
37,734
-5,076
| -12% | -$186K |
|
278
Instil Bio
TIL
$48.6M
| $1.43M | 0.02% |
6,636
-824
| -11% | -$193K |
|
279
Hecla Mining
HL
$10B
| $1.42M | 0.02% |
216,010
+65,454
| +43% | +$379K |
|
280
Keros Therapeutics
KROS
$205M
| $1.34M | 0.01% |
24,671
-2,400
| -9% | -$123K |
|
281
American Superconductor
AMSC
$1.42B
| $1.33M | 0.01% |
174,911
-57,322
| -25% | -$491K |
|
282
Immunocore
IMCR
$1.78B
| $1.32M | 0.01% |
44,226
-6,444
| -13% | -$163K |
|
|
BDN
283
Brandywine Realty Trust
BDN
$547M
| $1.29M | 0.01% |
90,961
-10,801
| -11% | -$146K |
|
|
MYOV
284
DELISTED
Myovant Sciences Ltd.
MYOV
| $1.28M | 0.01% |
96,505
-11,477
| -11% | -$154K |
|
285
ConocoPhillips
COP
$143B
| $1.28M | 0.01% |
12,835
+1,525
| +13% | +$140K |
|
286
Kinetik
KNTK
$3.61B
| $1.28M | 0.01% |
39,402
+29,754
| +308% | +$971K |
|
|
CPRX
287
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.26M | 0.01% |
152,241
-42,253
| -22% | -$299K |
|
288
StepStone Group
STEP
$3.66B
| $1.26M | 0.01% |
38,000
| – | – |
|
289
Recursion Pharmaceuticals
RXRX
$1.62B
| $1.24M | 0.01% |
173,678
-10,936
| -6% | -$116K |
|
290
AngloGold Ashanti
AU
$40.4B
| $1.23M | 0.01% |
51,731
+6,921
| +15% | +$150K |
|
291
Alector
ALEC
$170M
| $1.2M | 0.01% |
84,265
-9,791
| -10% | -$155K |
|
|
MRUS
292
DELISTED
Merus
MRUS
| $1.18M | 0.01% |
44,683
-5,367
| -11% | -$144K |
|
293
LXP Industrial Trust
LXP
$3.54B
| $1.18M | 0.01% |
15,036
-1,982
| -12% | -$150K |
|
294
Protagonist Therapeutics
PTGX
$8.86B
| $1.18M | 0.01% |
49,760
-5,472
| -10% | -$154K |
|
295
JPMorgan Chase
JPM
$943B
| $1.16M | 0.01% |
8,520
-2,420
| -22% | -$357K |
|
|
296
Verizon
VZ
$198B
| $1.16M | 0.01% |
22,797
-475,005
| -95% | -$25.2M |
|
297
ADC Therapeutics
ADCT
$151M
| $1.16M | 0.01% |
78,845
-9,944
| -11% | -$158K |
|
|
KYNB
298
Kyntra Bio
KYNB
$28.6M
| $1.15M | 0.01% |
3,823
-469
| -11% | -$163K |
|
299
Humana
HUM
$45.9B
| $1.13M | 0.01% |
2,606
-335
| -11% | -$140K |
|
|
EFC
300
Ellington Financial
EFC
$1.69B
| $1.13M | 0.01% |
63,466
-8,029
| -11% | -$141K |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, ALPS Advisors held 1,043 positions worth $9.22B, up 3.7% from $8.89B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
ALPS Advisors withdrew a net $371M in Q1 2022, closing 210 positions and reducing 486 holdings. Its most notable exit was Western Midstream Partners, an estimated $541M position sold in full.
By sector, the portfolio is most concentrated in Energy at 66% of assets, up from 59% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, ALPS Advisors opened a new position in Lucid Motors worth $40.8M.
- ALPS Advisors's largest Q1 2022 buy was Lucid Motors: 160,553 shares worth $40.8M.
- ALPS Advisors added most to Hess Midstream in Q1 2022, an estimated $149M increase.
- ALPS Advisors's biggest Q1 2022 reduction was Williams Companies, cutting an estimated $35.8M.
- ALPS Advisors fully exited Western Midstream Partners in Q1 2022, selling an estimated $541M.
- ALPS Advisors's ten largest holdings make up 56% of its $9.22B portfolio in Q1 2022.
- ALPS Advisors opened 155 new positions and closed 210 in Q1 2022.
- ALPS Advisors's portfolio value rose 3.7% quarter-over-quarter to $9.22B.
Based on ALPS Advisors's 13F filing for Q1 2022, filed 16 May 2022.